ADAMTS4 and breast carcinoma: Interestingly, the degradation of fibulin-2 by either ADAMTS-4 or ADAMTS-5 is blocked by the presence of ADAMTS-12 and seems to be a target for the protective role of the fibulin-2/ADAMTS-12 interaction in breast cancer (Figure 5).